Press Releases

BOCA RATON, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- Q.E.P. CO., INC. (OTCQX: QEPC) (the “Company” or “QEP”) today announced that the Board of Directors of the Company has declared a special cash dividend of $1.00 per share on its common stock. The dividend will be payable on or about June 26, 2024 to stockholders of record as of the close of business on May 31, 2024. After payment of this dividend, the Company will continue to have sufficient working capital to... (continue reading...)

THORNTON, Colo., May 15, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced it will participate in the 2024 Sidoti Small Cap Conference. MYR Group’s Chief Executive Officer, Rick Swartz, and Chief Financial Officer, Kelly Huntington, will meet virtually with... (continue reading...)

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the first quarter ended March 31, 2024.

"In the first quarter of 2024, we made the strategic decision to focus our resources on the commercialization of Camelina products targeting the aquafeed and nutritional markets for omega-3 fatty acids," said Oliver Peoples, Ph.D.,... (continue reading...)

Cincinnati, OH, May 15, 2024 (GLOBE NEWSWIRE) -- Ensemble Health Partners (Ensemble), the market leader in end-to-end revenue cycle outsourcing for mid-sized to large healthcare organizations, announced today the United States Patent and Trademark Office has granted Ensemble its tenth patent for its latest innovative technology to drive frictionless revenue cycle operations. The latest patented technology, named Next Best Action, predicts, optimizes and automates the... (continue reading...)

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medical devices.

“We are focused on maximizing shareholder value,” said Shai N. Gozani, M.D., Ph.D., Chief Executive Officer of NeuroMetrix. “Shareholders have recently... (continue reading...)